Adrian Haigh - Apr 15, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Adrian Haigh
Stock symbol
FENC
Transactions as of
Apr 15, 2024
Transactions value $
-$457,182
Form type
4
Date filed
4/16/2024, 06:00 PM
Previous filing
Aug 7, 2023
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale $51.3K +22.2K $2.31 22.2K Apr 15, 2024 Direct F1
transaction FENC Common Shares Sale $51.3K +22.2K +100% $2.31 44.4K Apr 16, 2024 Direct F2
transaction FENC Common Shares Sale -$229K -22.2K -50% $10.30 22.2K Apr 15, 2024 Direct F3
transaction FENC Common Shares Sale -$228K -22.2K -100% $10.28 0 Apr 16, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise -$51.3K -22.2K -4.5% $2.31 471K Apr 15, 2024 Options 22.2K $2.31 Direct F5
transaction FENC Common Shares Options Exercise -$51.3K -22.2K -4.71% $2.31 449K Apr 16, 2024 Options 22.2K $2.31 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F2 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F3 Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
F4 Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
F5 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
F6 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.